Navigation Links
Injury Lawyers Release New Infographic and Video about the Antidepressant Zoloft and Its Alleged Dangers
Date:7/22/2013

(PRWEB) July 22, 2013

Zoloft (sertaline hydrochloride) is a selective serotonin reuptake inhibitor (SSRI) which has been used to treat anxiety and depression. The drug was first approved by the FDA in 1991 and it has since earned Pfizer hundreds of millions of dollars. According to the company’s annual report, it earned over $537 million in sales in 2011 alone (i). In recent years, SSRI antidepressants like Zoloft have been the subject of FDA warnings and lawsuits. The FDA has issued two warnings on the potential link between SSRIs and persistent pulmonary hypertension in newborns (PPHN). The first warning about this link was issued in July 2006 but the most recent warning in December 2011 stated that medical studies have neither conclusively confirmed nor denied this link. After looking at the data, the FDA found that two studies suggested an increased risk of PPHN with SSRI use in pregnancy while three studies did not support this conclusion (ii).

Some women who took this drug during pregnancy have talked to Zoloft attorneys resulting in hundreds of birth defect lawsuits. These proceedings were consolidated through multidistrict litigation (MDL) on April 17, 2012 in the United States District Court for the Eastern District of Pennsylvania. According to a July 10, 2013 report from the Judicial Panel on Multidistrict Litigation, there have been a total of 412 lawsuits filed and there are currently 370 legal actions pending in the case of In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation - MDL 2342. These actions “involve allegations that Zoloft, a prescription medication approved for the treatment of depression and other ailments, causes birth defects in children when their mothers ingest the drug while pregnant” (iii).

The results of a recent medical study have suggested that patients who take SSRI drugs may face an increased risk of other adverse events. On April 29, 2013, the Journal of the American Medical Association for Internal Medicine published a study which looked at “whether perioperative use of SSRIs is associated with adverse outcomes of surgery in a national sample of patients.” The study looked at surgery outcomes from 375 hospitals and more than 534,000 patients who were taking SSRIs like Lexapro, Paxil, Prozac, and Zoloft, among others. It determined that these patients “had higher odds of in-hospital mortality, bleeding, and readmission at 30 days” (iv).

Attorney Paul d’Oliveira stated, “Depression is a very serious condition that doctors and manufacturers should approach appropriately. This means that doctors should tell patients about alternatives to prescription medicine and manufacturers should warn about the possible side effects of their drug. In my opinion, the medical industry has lost sight of the fact that they are treating real people. Treatment decisions need to be made on a person by person basis with the patient’s best interest in mind. Our law firm provides services with real people in mind and that is the reason that we have released our new informational graphic and video on Zoloft. We believe that awareness is an important step in empowering consumers.”

d'Oliveira & Associates has been investigating the safety of antidepressants, including SSRIs. Visit their website and view the Zoloft infographic and video. The law firm is currently working with some of the more experienced Zoloft lawyers in the country who are handling these birth defect lawsuits. Contact the firm to receive a free legal consultation and there are no legal fees unless you receive a settlement or award. Call toll-free at 1-800-922-6878 or fill out a contact form on their website in confidence.

(i) Pfizer 2012 Annual Report.
pfizer.com/files/annualreport/2012/financial/financial2012.pdf
(ii) FDA Drug Safety Communication, December 14, 2011.
fda.gov/Drugs/DrugSafety/ucm283375.htm
(iii) Judicial Panel on Multidistrict litigation, Pending MDL Dockets.
jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf
United States District Court for the Eastern District of Pennsylvania.
paed.uscourts.gov/mdl2342a.asp
(iv) JAMA Internal Medicine, April 29 2013.
archinte.jamanetwork.com/article.aspx?articleid=1682366

Read the full story at http://www.prweb.com/releases/2013/7/prweb10933416.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Injury Law Firm Releases New Informational Graphic about Workers’ Compensation in Rhode Island
2. The Berman Law Firm Now Offers Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases in Kendall, FL
3. Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases Are Now Offered By The Berman Law Group in Delray Beach, FL
4. Michigan Personal Injury Lawyers Announce Winner of 2013 Buckfire & Buckfire Diversity Scholarship
5. Sunrise FL Car Accident Lawyers The Berman Law Firm Now Offer Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases
6. Mahir Reiss Issues Comment On Injury Prevention Strategies
7. Changes in hyaluronan metabolism key in adaptation of keratinocytes to radiation injury
8. Rare weight lifting injury required surgery
9. 1 in 5 grade 7-12 students report having a traumatic brain injury in their lifetime
10. Drug-induced liver injury is on the rise
11. One in 5 students in Grades 7-12 say they have had a traumatic brain injury in their lifetime
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University ... specialty academic programs. , Answering to the increasing demand for curricular specializations, the ... law, and environmental and land use law. ,  , “The demand for lawyers ...
(Date:5/26/2016)... ... May 26, 2016 , ... The Woodlands at John Knox ... new model of care for living and healing, celebrated its grand opening, today. The ... a Real Home provided by Empowered Staff. , “This is an incredibly fulfilling time ...
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its line of ... Warner, New Hampshire at the MadgeTech headquarters. With products sold in more than 100 ... government agencies, including NASA. , In 2012, NASA strategically set up 17 RHTemp101A ...
(Date:5/26/2016)... ... ... An April Gallup survey found rising health care costs to be the top ... Living (SHSL) may not share those same worries thanks to a new bundled ... while holding the line on increasing their contributions, including premiums, deductibles and the portions ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership ... solutions, today announced the organization has earned its ISO 13485 certification, indicating the ... compliant with all rules and policies associated with ISO quality standard 13485. ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... the Dario™ Diabetes Management Tool, today announced that the Company,s ... the Marcum MicroCap Conference being held June 1-2 in ... Invitational, being held June 7-9 in Los Angeles, ... will discuss recent corporate and operational milestones, including the U.S. ...
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... TARE (Transarterial Radio-embolization) Using ... and Overall Decreased Use of Hospital Resource ... specialist healthcare company, has today announced the publication ... of ISPOR (International Society for Pharmacoeconomics and Outcomes ... using yttrium-90 glass microspheres is associated with cost ...
Breaking Medicine Technology: